20 June 2013
Keywords: positive, data, nobex, insulin, product, reported, promising
Article | 01 March 2004
NOBEX has reported promising Phase I/II data for its hexyl-insulin monoconjugate 2, an orally-active insulin in development for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 March 2004
19 June 2013
© 2013 thepharmaletter.com